Indefinite Delivery Contract 75D30120D08574
Award Date
7/1/20
Last Date to Order
6/30/21
Federal Agency
CDC Pittsburgh
Awardee
Merck Sharp & Dohme LLC
Ultimate Awardee
Schering Plough Corporation
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This federal contract indefinite delivery vehicle (IDV) was awarded to Grifols USA LLC by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to provide a variety of adult vaccines. The contract has a potential value of $1,647,100 and a period of performance from July 1, 2021 to June 30, 2022. The vaccines to be supplied under this IDV include hepatitis, pneumococcal, tetanus/diphtheria, herpes zoster, measles/mumps/rubella, meningococcal, human...
This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Merck Sharp & Dohme Corp., a subsidiary of Schering Plough Corporation, to provide vaccine-related services. The single-award contract has a ceiling value of $56,988,922.50 and a period of performance through February 28, 2011. The contract was not set aside and aims to procure vaccine storage and rotation services. This delivery order contract is one of...
The indefinite delivery contract (IDV) with ID 75D30119D05108 was awarded to Glaxosmithkline, LLC by the Centers for Disease Control and Prevention (CDC) for the delivery of adult vaccines. The $112,644,450 multiple award contract, which does not have any set-aside designations, has a period of performance from July 1, 2019 to June 30, 2024. Under this IDV, Glaxosmithkline provides a range of pharmaceutical goods and services as the prime contractor, including influenza virus and hepatitis...
This Indefinite Delivery Contract (IDC) award from the Centers for Disease Control and Prevention (CDC) is for the procurement of 12 standard adult vaccines to support state health department immunization programs. The $62,183,800 multiple-award contract has a period of performance from July 1, 2022 to June 30, 2023. The prime contractor is Pfizer Inc., a large pharmaceutical manufacturer that serves as a major federal supplier of medical products and vaccines. The contract requires the delivery...
The federal contract IDV award is for the supply of various adult vaccines to the Centers for Disease Control and Prevention (CDC) for the period of July 1, 2023 through June 30, 2024. The contract was awarded to Grifols USA LLC, a global healthcare company specializing in the manufacturing and distribution of plasma-derived medicines and pharmaceutical supplies. The contract has a ceiling value of $1,842,400.00 and includes the supply of 12 different adult vaccines, including hepatitis,...
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts under a competitive solicitation to purchase standard adult vaccines. The contracts have a one year period of performance from July 1, 2022 to June 30, 2023 and a combined potential value of $85.6 million. Merck Sharp & Dohme LLC was awarded one of these contracts as the prime contractor. The contracts enable the CDC to order 12 types of adult vaccines for delivery within 15 business days....
This is a multiple-award Indefinite Delivery Contract awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, for the procurement of various adult vaccines. The contract has a total ceiling value of $87,753,075 and a period of performance from July 1, 2023 to June 30, 2024. The contract aims to procure up to 1.5 to 3 million doses of 12 different adult vaccine types, including hepatitis, pneumococcal, tetanus, diphtheria, herpes...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, for the purchase of 20 standard pediatric vaccines. The contract supports the CDC's Vaccines for Children program and adult vaccination initiatives under Section 317(j) of the Public Health Service Act. This multiple award IDC has a total ceiling value of $2,565,312,500 and a period of performance of 12 months from the award date...
This multiple award IDV was issued by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to procure pediatric flu vaccines for the 2023-2024 flu season. Glaxosmithkline, LLC was awarded the IDV as prime contractor. The IDV does not include any set-asides and has a potential value of $174.9 million. Orders may be placed through February 2024 to deliver pediatric flu vaccines in support of the CDC's efforts to increase vaccination rates among...
The Centers for Disease Control and Prevention (CDC) has awarded a multiple-award Indefinite Delivery Contract (IDC) valued up to $69,520,654.32 to Merck Sharp & Dohme LLC, doing business as Merck, for the supply of various adult vaccines. The contract has a period of performance from July 1, 2024 to June 30, 2025 and does not involve any set-aside designations. The IDC requires Merck, as a pharmaceutical manufacturer, to provide a wide range of adult vaccines including Hepatitis A,...